Streetbeat News

Price Targets

STNG

JP Morgan analyst Samuel Bland has maintained an Overweight rating on Scorpio Tankers (NYSE:STNG) but reduced the price target from $83 to $73.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:01 pm

TW

Tradeweb Markets (NASDAQ:TW) has received updated analyst ratings in the last quarter, with 3 bullish, 5 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among 10 analysts is $96.3, with a high of $109.00 and a low of $81.00. This target reflects a 7.12% increase over the past month. Analyst ratings are based on future earnings predictions and company risk assessments, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:00 pm

ASUR

Asure Software (NASDAQ:ASUR) has received 7 analyst ratings in the last quarter, with 5 being bullish, 1 somewhat bullish, and 1 indifferent. The average 12-month price target among these analysts is $14.57, with a high of $20.00 and a low of $8.00. This target is a 2.87% decrease from the previous target of $15.00. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:00 pm

DVN

Devon Energy (NYSE:DVN) has received 13 analyst ratings in the last quarter, with an average 12-month price target of $57.23, a decrease of 2.37% from the previous target of $58.62. The ratings include 5 bullish, 1 somewhat bullish, and 7 indifferent, with no bearish ratings. The high price target is $79.00 and the low is $50.00.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:00 pm

ROIV

Roivant Sciences (NASDAQ:ROIV) received 8 analyst ratings in the last quarter, with 3 bullish, 5 somewhat bullish, and none bearish. The average 12-month price target for ROIV is $16.38, with a high of $23.00 and a low of $15.00. This target has increased by 9.2% over the past month.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:00 pm

CRWD

In the last quarter, CrowdStrike Holdings (NASDAQ:CRWD) received 45 analyst ratings, with 20 bullish, 21 somewhat bullish, and 4 indifferent. There were no somewhat bearish or bearish ratings. The average 12-month price target for CRWD is $192.33, with a high of $235.00 and a low of $153.00. This target has increased by 9.66% over the past month. Analysts rate stocks based on research and provide guidance on growth estimates, earnings, and revenue, although their ratings are subjective opinions.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:00 pm

LFMD

LifeMD (NASDAQ:LFMD) has received positive analyst ratings in the last quarter, with 1 bullish and 3 somewhat bullish ratings. No indifferent, somewhat bearish, or bearish ratings were reported. The average 12-month price target for LFMD is $8.5, with a high of $10.00 and a low of $7.00. This target has increased by 6.25% over the past month. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:00 pm

ETHUSD

Ethereum (CRYPTO: ETH) has seen a price drop of 5.89% in the last 24 hours, falling to $1,969.21, despite a 7.0% increase over the past week. The volatility of Ethereum is highlighted by the Bollinger Bands in the provided chart. Trading volume has risen by 5.0% over the week, and the circulating supply has slightly increased by 0.02% to over 120.26 million. Ethereum's market cap remains at $240.00 billion, maintaining its position as the second-largest cryptocurrency.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:00 pm

TSN

JP Morgan analyst Kenneth Goldman has maintained a Neutral rating on Tyson Foods (NYSE:TSN) and reduced the price target from $55 to $51.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:59 pm

ROIV

JP Morgan analyst Brian Cheng has maintained an Overweight rating on Roivant Sciences (NASDAQ:ROIV) but reduced the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 6:58 pm